Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 212
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04859751 | Study of VB4-845 Injection for Treating Patients With Non-muscle Invasive Bladder Cancer | ||
| NCT07348861 | A Phase II Study of Neoadjuvant Sacituzumab Tirumotecan in Combination With Iparomlimab and Tuvonralimab in Locally Advanced Cervical Cancer | ||
| NCT03770624 | A Study to Investigate the Safety, Efficacy and PK of Multiple Doses of QL-007 in Chronic Hepatitis B Patients in CHINA | ||
| NCT06749899 | QL1706 (PD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma. | ||
| NCT05058118 | Evaluation of the Safety, Tolerability and Pharmacokinetics of Intravenous FL058 Administered in Healthy Subjects(SAD) | ||
| NCT07040228 | A Phase Ib/II Clinical Study of Regorafenib Combined With Toripalimab and Albumin-bound Paclitaxel for the Third-line Treatment of Advanced Pancreatic Cancer | ||
| NCT07173595 | A Phase I Study of QLS2309 Injection in Patients With CD70+ Relapsed/Refractory Hematologic Malignancies | ||
| NCT05823285 | A Study Evaluates the Safety, Pharmacokinetics, Immunogenicity and Efficacy of QLS31903 in Advanced Solid Tumor Patients | ||
| NCT06500507 | A Study of QLS4131 in Patients With Recurrent or Refractory Multiple Myeloma | ||
| NCT07327697 | A Comparative Phase 1 Study to Evaluate the Pharmacokinetic and Safety of QL2302 vs. Tezspire® in Healthy Subjects | ||
| NCT07152444 | A Phase I Trial of QLS1410 in Healthy Chinese Adults and Participants With Mild Essential Hypertension | ||
| NCT07061639 | A Study of QLS5133 Monotherapy in Advanced Solid Tumors | ||
| NCT05801107 | Study to Investigate the Efficacy and Safety of WX-0593 in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients | ||
| NCT05758519 | A Study to Compare QLS1128 With Placebo in Symptomatic Participants With Mild to Moderate COVID-19 | ||
| NCT06371534 | A Study Comparing Pharmacokinetic and Safety of QL2109 and DARZALEX FASPRO® in Healthy Adults | ||
| NCT07453394 | QLS5132 Combination Therapy in Advanced Solid Tumors | ||
| NCT03267654 | Gefitinib With Chemotherapy or Anti-angiogenesis in NSCLC Patients With Bim Deletion or Low EGFR Mutation Abundance | ||
| NCT06614907 | A PhaseⅠ Comparative Study to Evaluate the Pharmacokinetics of QL2108 to Dupixent® | ||
| NCT07344051 | A Phase II Study of QLS12010 Capsules in Adults With Moderate to Severe Atopic Dermatitis | ||
| NCT04233151 | QL1203 In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy and Safety | ||
| NCT07025239 | QL1706 Injection Plus Bevacizumab and XELOX vs Placebo Plus Bevacizumab and XELOX as First-Line Treatment of Unresectable Metastatic Colorectal Cancer | ||
| NCT04435652 | A Study of QL1604 Plus Nab-paclitaxel Versus Paclitaxel in Subjects With Advanced Gastric Cancer. | ||
| NCT07450378 | QLC7401 in Participants With Heterozygous Familial Hypercholesterolemia (HeFH) | ||
| NCT05543343 | Staphylococcus and Neisseria Tablets in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease. | ||
| NCT06732323 | A Phase III Study of ESG401 for Unresectable Recurrent or Metastatic Triple-Negative Breast Cancer | ||
| NCT07463573 | QLC5508 vs. Chemotherapy in Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma | ||
| NCT05690945 | A Study of QL1706 in Combination With Chemotherapy in PD-L1-Negative Non-small Cell Lung Cancer | ||
| NCT05801094 | A Phase I Study of QL1604 for Advanced Solid Tumors | ||
| NCT02072785 | Phase III Study of Vincristine Sulfate Liposome For Injection In Adults With Naïve Acute Lymphoblastic Leukemia | ||
| NCT07258394 | Clinical Study for Dimethyl Fumarate in Preserving Islet β-Cell Function in Type 1 Diabetes Mellitus | ||
| NCT04954456 | A Study of Bispecific Antibody QLS31901 in Patients With Advanced or Metastatic Malignancies | ||
| NCT04550949 | To Evaluate the Efficacy and Safety of QL1206 and Xgeva in Patients With Bone Metastases From Solid Tumors | ||
| NCT06254235 | Bioequivalence Study of Two Octreotide Microsphere Formulations in Healthy Volunteers | ||
| NCT04234594 | Comparing the Pharmacokinetic and Safety of QL1203 and Vectibix® in Healthy Males. | ||
| NCT07001839 | A Phase Ib Study of QLS4131 in Subjects With Systemic Lupus Erythematosus | ||
| NCT03195569 | To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in Study of QL1101 and Avastin® in Patients With Non-squamous Non-small Cell Lung Cancer | ||
| NCT04632758 | Study Comparing WX-0593 to Crizotinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients | ||
| NCT05052567 | CEND-1 Injection (QLC12102) in Patients With Advanced Metastatic Pancreatic Ductal Adenocarcinoma | ||
| NCT06760676 | A Multiple Tumor Species, Open and Multi-center Clinical Study of Alpaloritovorelli Antibodies (QL-1706) Combined with Pulsed Low Dose Rate External Irradiation (PLDR) for Disease Progression After Previous Anti-tumor Therapy | ||
| NCT04641754 | A Study Evaluates the Safety and Efficacy of WX-0593 in ALK -Positive, or ROS1-positive Non-small Cell Lung Cancer | ||
| NCT06750341 | Study of QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated LDL Cholesterol | ||
| NCT05058105 | Safety, Tolerability, Pharmacokinetics of Intravenous FL058 and Meropenem in Healthy Subjects(SAD/MAD) | ||
| NCT07345000 | A Study of Romiplostim N01 Plus IST vs. Placebo Plus IST for Treatment-Naive Severe Aplastic Anemia | ||
| NCT05976568 | A Study of QL1706 in Combination With Bevacizumab and/or Chemotherapy as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma | ||
| NCT06884891 | A Phase Ⅲ Comparative Study of QL2108 to Dupixent® | ||
| NCT06925659 | A Study of QLM2011 in Subjects With Advanced Solid Tumors | ||
| NCT05932888 | Safety, Tolerability, and Pharmacokinetic Study of QLM3003 in Healthy Adult Subjects | ||
| NCT03104010 | A Non-inferiority Phase 2 Study to Evaluate the Safety and Efficacy of PEG-rhGH in the Treatment of AGHD | ||
| NCT06007586 | Prevention and Treatment of CINV Caused by TC Regimen in Gynecological Malignant Tumor Patients | ||
| NCT06058000 | A Phase 2 Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis |
